Beer & Biotech
October 18 @ 4:30 pm - 6:30 pm
BEAM: Setting the Standard for Proactive Behavioral Healthcare
Healthcare providers are expected to treat more behavioral health needs than ever before. This creates a healthcare industry centered around reactive measures that are costly to patient health and healthcare systems. BEAM Diagnostics, Inc. developed Beacon, a digital assessment platform that simplifies assessment delivery. Beacon equips providers with accessible, predictive technology that improves the proactive quality of care for patients. Dr. Sarah Snider, BEAM Co-Founder and CEO, will discuss the difficulty of addressing behavioral health needs, how BEAM is setting the standard for proactive assessments, and what that means for the future of healthcare.
About the Speaker
Dr. Sarah Snider
Dr. Snider is an experienced behavioral pharmacologist in the field of substance use disorder and decision-making. She has led BEAM through the successful execution of NIH-and-regionally-funded small business technology transfer grant projects and the validation and commercialization of Beacon and its assessment modules. She earned her Ph.D. at Virginia Commonwealth University in Pharmacology and Toxicology.